GENEVA, Switzerland — Operating on the spine is not brain surgery and remains a physical, hands-on intervention
Products
New self-expanding stent used for first time
Three patients with established cardiac ischemia recently became the first recipients of the vProtect Luminal Shield
Medtronic awarded $250m damages in patent pcase
A federal jury found that Boston Scientific has infringed three patents owned by Medtronic
Medical Devices Directives may be revised
The European Commission is considering a revision of the legal framework in Europe for Medical Devices.
Unsolicited drug samples sent, complaint upheld
Four healthcare professionals complained about receiving unsolicited samples from Resource Medical UK Limited.
MD Alert affecting LogiCal, NovaTrans and TranStar
MDA/2008/036: Invasive blood pressure monitoring sets: LogiCal, NovaTrans and TranStar models with trigger flush device
Eucomed Guidelines on HP interaction
As a medical professional or an industry worker you need to understand how to ethically deal with one another.
Smith and Nephew UK CALAXO Screw Recall
The United Kingdom has issued the immediate recall of all CALAXO Osteoconducive Interference Screws, used in Anterior Cruciate Ligament (ACL) reconstructive surgery.
Surgeon’s Contamination Invention Gets UK Launch
An orthopaedic surgeon’s brainchild invention, the Clinicon Lavage Tray looks set to help reduce the risk of superbug contamination within hospitals.
Orthopaedic Medical Devices & Bad Backs
It’s all in the joints. Buy shares in medical technology companies!
Nasdaq Closes Review of ArthroCare
Nasdaq Closes Its Review of ArthroCare’s Prior Relationship With DiscoCare Unit
ArthroCare’s Device Sales Relationships Questioned
ArthroCare investors might want to read some past editions of The Palm Beach Post.
Gyrus Shares down on Arthrocare Patent Dispute (Update1)
The UK-based maker of surgical instruments, fell 0.8 percent in London after U.S. surgical equipment maker ArthroCare Corp. sued for patent infringement
Schering-Plough gets clearance from FT Commission
Schering-Plough Corporation announced it has received antitrust clearance for its acquisition of Organon BioSciences N.V. from Akzo Nobel N.V.